Published in AIDS Weekly, May 5th, 2003
Virucort is a drug developed by Dr. Alfred T. Sapse that has the potential of slowing down or even preventing an HIV+ individual from progressing to full blown AIDS.
Virucort was shown in clinical studies, including double-blind, to control two factors important in the progress from HIV to AIDS.
Alfred T. Sapse, MD, and Cortisol Medical Research are currently seeking financial and joint venture partners.
This article was prepared by AIDS Weekly editors from staff and other reports. Copyright 2003, AIDS Weekly via...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.